Jim Simons Akouos, Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.16 $21,840 - $43,344	8,400 Added 9.29%	98,800 $668,000
Q2 2022 Aug 12, 2022	BUY	$2.46 - $5.2 $140,712 - $297,440	57,200 Added 172.29%	90,400 $424,000
Q1 2022 May 13, 2022	BUY	$4.16 - $9.08 $77,792 - $169,796	18,700 Added 128.97%	33,200 $158,000
Q4 2021 Feb 11, 2022	BUY	$7.65 - $11.38 $110,925 - $165,010	14,500 New	14,500 $123,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.